311 related articles for article (PubMed ID: 20841490)
21. Treatment of membranous lupus nephritis.
Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
[TBL] [Abstract][Full Text] [Related]
22. Secondary IgA nephropathy presenting as nephrotic syndrome with glomerular crescentic changes and acute renal failure in a patient with autoimmune hepatitis.
Singri N; Gleason B; Flamm SL; Kanwar YS; Ghossein C
J Nephrol; 2004; 17(1):125-9. PubMed ID: 15151269
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
25. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
Yakupoğlu U; Baranowska-Daca E; Suki WN; Truong LD
Transplant Proc; 2004; 36(1):139-43. PubMed ID: 15013326
[TBL] [Abstract][Full Text] [Related]
26. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
[TBL] [Abstract][Full Text] [Related]
27. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
28. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
29. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
31. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
32. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
33. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
35. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
36. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
[TBL] [Abstract][Full Text] [Related]
37. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
38. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
39. [Demonstration of mesangial IgA deposits in kidney biopsies of pediatric patients: comparison with the clinical picture].
Kern BE; di Rocco D; Lütschg J; Lüthy C; Zimmermann A; Gerber HA; Oetliker OH; Bianchetti MG
Praxis (Bern 1994); 1995 Oct; 84(41):1158-64. PubMed ID: 7481326
[TBL] [Abstract][Full Text] [Related]
40. Membranous nephropathy. Long-term follow-up and association with neoplasia.
Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
